Nippon Shinyaku
Japan - KyotoBiotechnology
Focus: Nippon Shinyaku is a Japanese biotechnology company headquartered in Kyoto specializing in small molecules and biologics across rare diseases, cardiovascular, and hematology. The company operates at mid-cap scale with a focused pipeline of 13 clinical programs.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Nippon Shinyaku
AI assessmentNot HiringNo open roles listed right now. Follow Nippon Shinyaku to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak7.9yr
Cornerstone commercial asset with 10+ year patent exclusivity providing revenue stability and competitive moat in exon-skipping therapies for DMD.
Help build intelligence for Nippon Shinyaku
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.